Completion of Facility Enables Initiation of Phase 3 Clinical Trial of Nepafenac in Patients Undergoing Cataract Surgery AUSTIN, Texas, Sept. 12, 2023 /PRNewswire/ -- Mati Therapeutics Inc. ("Mati") ...

A corticosteroid-loaded punctum plug significantly reduced inflammation and pain after cataract surgery, according to results of a phase 2 clinical trial. The hydrogel plug (dexamethasone, Ocular ...

CHICAGO — A tapered-release dexamethasone punctum plug appears to be a reasonable alternative to medicated eye drops for patients who have undergone cataract surgery, according to early research. "In ...

Lacrimal drainage plugs improve the signs and symptoms of moderate dry eye and are well tolerated in eyes that do not benefit from topical lubrication, according to 27 level 2 and 3 studies culled ...

A retrospective administrative claims analysis of treatment options for dry eye disease (DED) evaluated treatment patterns and utilization characteristics of patients receiving cyclosporine, punctal ...

QLT Inc. announced results of its phase II clinical study on the efficacy and safety of the Latanoprost Punctal Plug Delivery System (LPPDS) in subjects with Ocular Hypertension (OH) and Open-Angle ...

A technology assessment report by the American Academy of Ophthalmology showed that more than half of all lacrimal drainage plug placements led to reduced dry eye symptoms, improved ocular surface ...

AUSTIN, Texas, Sept. 12, 2023 /PRNewswire/ -- Mati Therapeutics Inc. ("Mati") announced that it has completed and now occupies a facility dedicated to manufacturing all products formulated in Mati's ...